Evaluation of the VU-AMS device in pediatric cardiology

Evaluation of the VU-AMS device in pediatric cardiology - Evaluation of the VU-AMS device in pediatric cardiology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38626

Enrollment

150

Registered

2013-12-10

Start date

2014-02-10

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease heart disease

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Healthy, aged between 1 and 18

Exclusion criteria

Exclusion criteria: Heart disease, any chronic disorder, medication use

Design outcomes

Primary

Measure	Time frame
The most important study variables are: Stroke volume(SV): the amount of blood leaving the heart with a single heartbeat. Pre Ejection Period (PEP); The time between the onset of the electrical activation of the ventricles and the mechanical activation of the ventricles (opening of the aortic valve). This is a measure of sympathetic activity and contractility of the heart muscle. Respiratory sinus arrhythmia (RSA); this is a naturally occurring variation in heart frequency during a breathing cycle. RSA is the difference in time between the shortest two successive heart beats and the slowest.	—

Measure

Time frame

The most important study variables are: Stroke volume(SV): the amount of blood leaving the heart with a single heartbeat. Pre Ejection Period (PEP); The time between the onset of the electrical activation of the ventricles and the mechanical activation of the ventricles (opening of the aortic valve). This is a measure of sympathetic activity and contractility of the heart muscle. Respiratory sinus arrhythmia (RSA); this is a naturally occurring variation in heart frequency during a breathing cycle. RSA is the difference in time between the shortest two successive heart beats and the slowest.

—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results